Cited by 357Metabolism, Diabetes, and CancerCancer, Hypoxia, and MetabolismCancer, Lipids, and Metabolism

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid β-oxidation

Buzzai, Monica, Bauer, Daniel E, Jones, Russell G, DeBerardinis, Ralph J, Hatzivassiliou, Georgia, Elstrom, Rebecca L, Thompson, Craig B·2005·Oncogene

DOI 10.1038/sj.onc.1208622

Open this paper in CoChat — free account

Abstract

Activation of the oncogenic kinase Akt stimulates glucose uptake and metabolism in cancer cells and renders these cells susceptible to death in response to glucose withdrawal. Here we show that 5-aminoimidazole-4-carboxamide ribonucleoside (AICAR) reverses the sensitivity of Akt-expressing glioblastoma cells to glucose deprivation. AICAR's protection depends on the activation of AMPK, as expression of a dominant-negative form of AMPK abolished this effect. AMPK is a cellular energy sensor whose activation can both block anabolic pathways such as protein synthesis and activate catabolic reactions such as fatty acid oxidation to maintain cellular bioenergetics. While rapamycin treatment mimicked the effect of AICAR on inhibiting markers of cap-dependent translation, it failed to protect Akt-expressing cells from death upon glucose withdrawal. Compared to control cells, Akt-expressing cells were impaired in the ability to induce fatty acid oxidation in response to glucose deprivation unless stimulated with AICAR. Stimulation of fatty acid oxidation was sufficient to maintain cell survival as activation of fatty acid oxidation with bezafibrate also protected Akt-expressing cells from glucose withdrawal-induced death. Conversely, treatment with a CPT-1 inhibitor to block fatty acid import into mitochondria prevented AICAR from stimulating fatty acid oxidation and promoting cell survival in the absence of glucose. Finally, cell survival did not require reversal of Akt's effects on either protein translation or lipid synthesis as the addition of the cell penetrant oxidizable substrate methyl-pyruvate was sufficient to maintain survival of Akt-expressing cells deprived of glucose. Together, these data suggest that activation of Akt blocks the ability of cancer cells to metabolize nonglycolytic bioenergetic substrates, leading to glucose addiction.

Integrity signals

Registry

Crossref · 10.1038/sj.onc.1208622

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

TSC2 Mediates Cellular Energy Response to Control Cell Growth and Survival
Inoki, K., Zhu, T., & Guan, K.-L. (2003) · Cell · doi:10.1016/s0092-8674(03)00929-2 · Cited by 3,914
On Respiratory Impairment in Cancer Cells
Warburg, O. H. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,472
Cellular energy utilization and molecular origin of standard metabolic rate in mammals
Rolfe, D. F., & Brown, G. C. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.3.731 · Cited by 2,021
Roles of PPARs in health and disease
Kersten, S., Desvergne, B., & Wahli, W. (2000) · Nature · doi:10.1038/35013000 · Cited by 1,956
Akt Stimulates Aerobic Glycolysis in Cancer Cells
Elstrom, R. L., Bauer, D. E., Buzzai, M., Karnauskas, R., Harris, M. H., Plas, D. R., Zhuang, H., Cinalli, R. M., Alavi, A., Rudin, C. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2904 · Cited by 1,454
Self-citation
5-Aminoimidazole-4-Carboxamide Ribonucleoside. A Specific Method for Activating AMP-Activated Protein Kinase in Intact Cells?
Corton, J. M., Gillespie, J. G., Hawley, S. A., & Hardie, D. G. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20498.x · Cited by 1,232
Oncogenic alterations of metabolism
Dang, C. V., & Semenza, G. L. (1999) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(98)01344-9 · Cited by 1,106
AICA riboside increases AMP-activated protein kinase, fatty acid oxidation, and glucose uptake in rat muscle
Merrill, G. F., Kurth, E. J., Hardie, D. G., & Winder, W. W. (1997) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1997.273.6.e1107 · Cited by 1,048
Minireview: The AMP-Activated Protein Kinase Cascade: The Key Sensor of Cellular Energy Status
Hardie, D. G. (2003) · Endocrinology · doi:10.1210/en.2003-0982 · Cited by 994
Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase
Gottlob, K., Majewski, N., Kennedy, S., Kandel, E., Robey, R. B., & Hay, N. (2001) · Genes & Development · doi:10.1101/gad.889901 · Cited by 961

Show all 29 references

Research works printed but not linked: 1

Corton JM, Gillespie JG, Hawley SA and Hardie DG . (1995). Eur. J. Biochem., 229, 558–565. · DOI

Sorted by citations

Items 101–200 of 356

Metabolic reprogramming of the tumour microenvironment
Xing, Y., Zhao, S., Zhou, B. P., & Mi, J. (2015) · The FEBS Journal · doi:10.1111/febs.13402 · Cited by 108
Peroxiredoxin 2 specifically regulates the oxidative and metabolic stress response of human metastatic breast cancer cells in lungs
Stresing, V., Baltziskueta, E., Rubio, N., Blanco, J., de Arriba, M., Valls, J., Janier, M. F., Clézardin, P., Pamplona, R. S., Nieva, C., et al. (2012) · Oncogene · doi:10.1038/onc.2012.93 · Cited by 109
MyoD Regulates Skeletal Muscle Oxidative Metabolism Cooperatively with Alternative NF-κB
Shintaku, J., Peterson, J. M., Talbert, E. E., Gu, J.-M., Ladner, K. J., Williams, D. R., Mousavi, K., Wang, R., Sartorelli, V., & Guttridge, D. C. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.010 · Cited by 108
Shikonin Directly Targets Mitochondria and Causes Mitochondrial Dysfunction in Cancer Cells
Wiench, B., Eichhorn, T., Paulsen, M. S., & Efferth, T. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/726025 · Cited by 104
Starved and Asphyxiated: How Can CD8+ T Cells within a Tumor Microenvironment Prevent Tumor Progression
Zhang, Y., & Ertl, H. C. J. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00032 · Cited by 102
Akt Requires Glucose Metabolism to Suppress Puma Expression and Prevent Apoptosis of Leukemic T Cells
Coloff, J. L., Mason, E. F., Altman, B. J., Gerriets, V. A., Liu, T., Nichols, A., Zhao, Y., Wofford, J. A., Jacobs, S. R., Ilkayeva, O., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.179101 · Cited by 103
The Crosstalk Between Cell Adhesion and Cancer Metabolism
Sousa, B., Pereira, J., & Paredes, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081933 · Cited by 106
Mitochondrial Dysfunction in Cancer and Neurodegenerative Diseases: Spotlight on Fatty Acid Oxidation and Lipoperoxidation Products
Barrera, G., Gentile, F., Pizzimenti, S., Canuto, R. A., Daga, M., Arcaro, A., Cetrangolo, G. P., Lepore, A., Ferretti, C., Dianzani, C., et al. (2016) · Antioxidants · doi:10.3390/antiox5010007 · Cited by 98
Nutrient sensor O-GlcNAc transferase controls cancer lipid metabolism via SREBP-1 regulation
Sodi, V. L., Bacigalupa, Z. A., Ferrer, C. M., Lee, J. V., Gocal, W. A., Mukhopadhyay, D., Wellen, K. E., Ivan, M., & Reginato, M. J. (2017) · Oncogene · doi:10.1038/onc.2017.395 · Cited by 99
Therapeutic Targeting of Aldolase A Interactions Inhibits Lung Cancer Metastasis and Prolongs Survival
Chang, Y., Chiou, J., Yang, Y.-F., Su, C., Lin, Y., Yang, C.-N., Lu, P., Huang, M., Yang, C.-J., & Hsiao, M. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-4080 · Cited by 101
Group X secreted phospholipase A2 induces lipid droplet formation and prolongs breast cancer cell survival
Pucer, A., Brglez, V., Payré, C., Pungerčar, J., Lambeau, G. J., & Petan, T. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-111 · Cited by 96
Role of [18F]FDG PET in prediction of KRAS and EGFR mutation status in patients with advanced non-small-cell lung cancer
Caicedo, C., García‐Velloso, M. J., Lozano, M. D., Labiano, T., Díaz, C. V., López-Picazo, J. M., Gúrpide, A., Zulueta, J. J., Richter, J. Á., & Perez‐Gracia, J. L. (2014) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-014-2833-4 · Cited by 93
Glioblastoma Utilizes Fatty Acids and Ketone Bodies for Growth Allowing Progression during Ketogenic Diet Therapy
Sperry, J., Condro, M. C., Guo, L., Braas, D., VanderVeer-Harris, N., Kim, K. K. O., Pope, W. B., Divakaruni, A. S., Lai, A., Christofk, H. R., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101453 · Cited by 88
Role of 18F-Fluorodeoxyglucose Positron Emission Tomography in Predicting Epidermal Growth Factor Receptor Mutations in Non-Small Cell Lung Cancer
Mak, R. H., Digumarthy, S. R., Muzikansky, A., Engelman, J. A., Shepard, J.-A. O., Choi, N. C., & Sequist, L. V. D. (2011) · The Oncologist · doi:10.1634/theoncologist.2010-0300 · Cited by 89
Loss of GLUT4 Induces Metabolic Reprogramming and Impairs Viability of Breast Cancer Cells
Garrido, P., Osorio, F. G., Morán, J., Cabello, E., Alonso, A., Freije, J. M. P., & González, C. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24698 · Cited by 87
Metabolic stress in cancer cells induces immune escape through a PI3K-dependent blockade of IFNγ receptor signaling
Marijt, K. A., Sluijter, M., Blijleven, L., Tolmeijer, S. H., Scheeren, F. A., van der Burg, S. H., & van Hall, T. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-019-0627-8 · Cited by 85
Isolation of strawberry anthocyanin-rich fractions and their mechanisms of action against murine breast cancer cell lines
Mazzoni, L., Giampieri, F., Álvarez-Suárez, J. M., Gasparrini, M., Mezzetti, B., Forbes-Hernández, T. Y., & Battino, M. A. (2019) · Food & Function · doi:10.1039/c9fo01721f · Cited by 83
Novel drugs that target the metabolic reprogramming in renal cell cancer
van der Mijn, J. C., Panka, D. J., Geissler, A. K., Verheul, H. M. W., & Mier, J. W. (2016) · Cancer & Metabolism · doi:10.1186/s40170-016-0154-8 · Cited by 83
Dysregulation of Glucose Metabolism by Oncogenes and Tumor Suppressors in Cancer Cells
Marbaniang, C., & Kma, L. (2018) · Europe PMC (PubMed Central) · doi:10.22034/apjcp.2018.19.9.2377 · Cited by 82
VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR–PI3K–AKT pathway
Zhangyuan, G., Wang, F., Zhang, H., Jiang, R., Tao, X., Yu, D., Jin, K., Yu, W., Liu, Y., Yin, Y., et al. (2019) · Oncogene · doi:10.1038/s41388-019-1052-7 · Cited by 80
Cancer's sweet tooth: the Janus effect of glucose metabolism in tumorigenesis
Ashrafian, H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68228-7 · Cited by 79
Molecular mechanisms of tumor suppression by LKB1
Vaahtomeri, K., & Mäkelä, T. P. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.12.034 · Cited by 78
Transketolase protein TKTL1 overexpression: A potential biomarker and therapeutic target in breast cancer
Földi, M., Stickeler, E., Bau, L. A., Kretz, O., Watermann, D. O., Gitsch, G., Kayser, G., Hausen, A. Z., & Coy, J. (2007) · Oncology Reports · doi:10.3892/or.17.4.841 · Cited by 75
Effect of Fatty Acids on Human Bone Marrow Mesenchymal Stem Cell Energy Metabolism and Survival
Fillmore, N., Huqi, A., Jaswal, J. S., Mori, J., Paulin, R., Haromy, A., Onay-Beşi̇kçi̇, A., Ionescu, L., Thébaud, B., Michelakis, E. D., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120257 · Cited by 75
Extracellular Matrix Regulation of Metabolism and Implications for TumorigenesisPreprint
Grassian, A. R., Coloff, J. L., & Brugge, J. S. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010967 · Cited by 80
Complementary ACSL isoforms contribute to a non-Warburg advantageous energetic status characterizing invasive colon cancer cells
Sánchez‐Martínez, R., Cruz-Gil, S., García-Álvarez, M. S., Reglero, G., & de Molina, A. R. (2017) · Scientific Reports · doi:10.1038/s41598-017-11612-3 · Cited by 72
A novel mutation panel for predicting etoposide resistance in small-cell lung cancer
Qiu, Z., Lin, A., Li, K., Lin, W., Wang, Q., Wei, T., Zhu, W., Luo, P., & Zhang, J. (2019) · Drug Design Development and Therapy · doi:10.2147/dddt.s205633 · Cited by 74
Tumor microenvironmental nutrients, cellular responses, and cancer
Lobel, G. P., Jiang, Y., & Simon, M. C. (2023) · Cell chemical biology · doi:10.1016/j.chembiol.2023.08.011 · Cited by 78
Method for Lipidomic Analysis: p53 Expression Modulation of Sulfatide, Ganglioside, and Phospholipid Composition of U87 MG Glioblastoma Cells
He, H., Conrad, C. A., Nilsson, C. L., Ji, Y., Schaub, T. M., Marshall, A. G., & Emmett, M. R. (2007) · Analytical Chemistry · doi:10.1021/ac071413m · Cited by 74
Mitochondria-centric bioenergetic characteristics in cancer stem-like cells
Shin, M., & Cheong, J. (2019) · Archives of Pharmacal Research · doi:10.1007/s12272-019-01127-y · Cited by 72
The dark face of AMPK as an essential tumor promoter
Jeon, S., & Hay, N. (2012) · Cellular Logistics · doi:10.4161/cl.22651 · Cited by 71
Glycolytic Phenotype and AMP Kinase Modify the Pathologic Response of Tumor Xenografts to VEGF Neutralization
Nardo, G., Favaro, E., Curtarello, M., Moserle, L., Zulato, E., Persano, L., Rossi, E. M. C., Esposito, G., Crescenzi, M., Casanovas, O., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-0242 · Cited by 75
Classical NF-κB Metabolically Reprograms Sarcoma Cells Through Regulation of Hexokinase 2
Londhe, P., Yu, P. Y., Ijiri, Y., Ladner, K. J., Fenger, J. M., London, C. A., Houghton, P. J., & Guttridge, D. C. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00104 · Cited by 71
Estrogen Modulates Metabolic Pathway Adaptation to Available Glucose in Breast Cancer Cells
O’Mahony, F., Razandi, M., Pedram, A., Harvey, B. J., & Levin, E. R. (2012) · Molecular Endocrinology · doi:10.1210/me.2012-1191 · Cited by 69
High mitochondria content is associated with prostate cancer disease progression
Grupp, K., Jedrzejewska, K., Tsourlakis, M. C., Koop, C., Wilczak, W., Adam, M., Quaas, A., Sauter, G., Simon, R., Izbicki, J. R., et al. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-145 · Cited by 70
Metabolic heterogeneity in cancer: An overview and therapeutic implications
Yu, T., Gao, W., & Liu, Y. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188421 · Cited by 70
Protein Lipidation by Palmitoylation and Myristoylation in Cancer
Fhu, C. W., & Ali, A. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.673647 · Cited by 70
Balancing biosynthesis and bioenergetics: metabolic programs in oncogenesis
Barger, J. F., & Plas, D. R. (2010) · Endocrine Related Cancer · doi:10.1677/erc-10-0106 · Cited by 65
Non-Invasive Tumor Genotyping Using Radiogenomic Biomarkers, a Systematic Review and Oncology-Wide Pathway Analysis
Jansen, R. W., van Amstel, P., Martens, R. M., Kooi, I. E., Wesseling, P., de Langen, A. J., Menke-Van der Houven van Oordt, C. W., Jansen, B. H. E., Moll, A. C., Dorsman, J. C., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24893 · Cited by 63
Characterization of Changes in the Proteome in Different Regions of 3D Multicell Tumor Spheroids
McMahon, K. M., Volpato, M., Chi, H. Y., Musiwaro, P., Poterlowicz, K., Peng, Y., Scally, A., Patterson, L. H., Phillips, R. M., & Sutton, C. W. (2012) · Journal of Proteome Research · doi:10.1021/pr2012472 · Cited by 66
The structure and allosteric regulation of glutamate dehydrogenase
Li, M., Li, C., Allen, A., Stanley, C. A., & Smith, T. J. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.10.017 · Cited by 67
HuR is a post-transcriptional regulator of core metabolic enzymes in pancreatic cancer
Burkhart, R. A., Pineda, D. M., Chand, S. N., Romeo, C., Londin, E. R., Karoly, E. D., Cozzitorto, J. A., Rigoutsos, I., Yeo, C. J., Brody, J. R., et al. (2013) · RNA Biology · doi:10.4161/rna.25274 · Cited by 64
The role of LKB1 in lung cancer
Sánchez‐Céspedes, M. (2011) · Familial Cancer · doi:10.1007/s10689-011-9443-0 · Cited by 66
Autophagy: a targetable linchpin of cancer cell metabolism
Leone, R. D., & Amaravadi, R. K. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.01.008 · Cited by 68
Anoikis in cancer: The role of lipid signaling
Raeisi, M., Zehtabi, M., Velaei, K., Fayyazpour, P., Aghaei, N., & Mehdizadeh, A. (2022) · Cell Biology International · doi:10.1002/cbin.11896 · Cited by 62
Anticancer Properties of PPARα‐Effects on Cellular Metabolism and Inflammation
Grabacka, M., & Reiss, K. (2008) · PPAR Research · doi:10.1155/2008/930705 · Cited by 66
Akt Isoforms: A Family Affair in Breast Cancer
Basu, A., & Lambring, C. B. (2021) · Cancers · doi:10.3390/cancers13143445 · Cited by 62
Exosomes carrying ALDOA and ALDH3A1 from irradiated lung cancer cells enhance migration and invasion of recipients by accelerating glycolysis
Wang, C., Xu, J., Yuan, D., Bai, Y., Pan, Y., Zhang, J., & Shao, C. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03729-3 · Cited by 61
Myeloid-derived suppressor cells induce multiple myeloma cell survival by activating the AMPK pathway
Veirman, K. D., Menu, E., Maes, K., Beule, N. D., Smedt, E. D., Maes, A., Vlummens, P., Fostier, K., Kassambara, A., Moreaux, J., et al. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.11.002 · Cited by 60
Inhibitors of lipogenic enzymes as a potential therapy against cancer
Montesdeoca, N., López, M., Ariza, X., Herrero, L., & Makowski, K. (2020) · The FASEB Journal · doi:10.1096/fj.202000705r · Cited by 58
Cellular metabolism in colorectal carcinogenesis: Influence of lifestyle, gut microbiome and metabolic pathways
Hagland, H. R., & Søreide, K. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.02.026 · Cited by 59
From cancer metabolism to new biomarkers and drug targets
Chiaradonna, F., Moresco, R. M., Airoldi, C., Gaglio, D., Palorini, R., Nicotra, F., Messa, C., & Alberghina, L. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.07.006 · Cited by 61
Glycolytic phenotype in breast cancer: activation of Akt, up-regulation of GLUT1, TKTL1 and down-regulation of M2PK
Schmidt, M., Voelker, H.-U., Kapp, M., Krockenberger, M., Dietl, J., & Kämmerer, U. (2009) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-009-0652-y · Cited by 59
Elevated Expression of DecR1 Impairs ErbB2/Neu-Induced Mammary Tumor Development
Ursini‐Siegel, J., Rajput, A. B., Lu, H., Sanguin‐Gendreau, V., Zuo, D., Papavasiliou, V., Lavoie, C. A., Turpin, J., Cianflone, K., Huntsman, D. D., et al. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00686-07 · Cited by 58
Perturbation of energy metabolism by fatty-acid derivative AIC-47 and imatinib in BCR-ABL-harboring leukemic cells
Shinohara, H., Kumazaki, M., Minami, Y., Ito, Y., Sugito, N., Kuranaga, Y., Taniguchi, K., Yamada, N. O., Otsuki, Y., Naoe, T., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.11.020 · Cited by 58
Progress and Prospects of Reactive Oxygen Species in Metal Carcinogenesis
Wang, L., Wise, J. T. F., Zhang, Z., & Shi, X. (2016) · Current Pharmacology Reports · doi:10.1007/s40495-016-0061-2 · Cited by 59
A Rise in ATP, ROS, and Mitochondrial Content upon Glucose Withdrawal Correlates with a Dysregulated Mitochondria Turnover Mediated by the Activation of the Protein Deacetylase SIRT1
Song, S. B., & Hwang, E. S. (2018) · Cells · doi:10.3390/cells8010011 · Cited by 57
Metabolic Modulation of Epigenetics in Gliomas
Venneti, S., & Thompson, C. B. (2013) · Brain Pathology · doi:10.1111/bpa.12022 · Cited by 56
Self-citation
The role of glucose metabolism and glucose-associated signalling in cancer.
Wittig, R., & Coy, J. F. (2008) · PubMed Central · Cited by 56
Kinase Suppressor of Ras 2 (KSR2) Regulates Tumor Cell Transformation via AMPK
Fernandez, M. R., Henry, M. D., & Lewis, R. E. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.06754-11 · Cited by 60
Kinase Suppressor of Ras 1 (KSR1) Regulates PGC1α and Estrogen-Related Receptor α To Promote Oncogenic Ras-Dependent Anchorage-Independent Growth
Fisher, K. W., Das, B., Kortum, R. L., Chaika, O. V., & Lewis, R. E. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.05255-11 · Cited by 60
Impact of chemotherapy on metabolic reprogramming: Characterization of the metabolic profile of breast cancer MDA-MB-231 cells using 1 H HR-MAS NMR spectroscopy
Maria, R. M., Altei, W. F., Selistre-de-Araújo, H. S., & Colnago, L. A. (2017) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2017.08.038 · Cited by 56
Metabolic role of fatty acid binding protein 7 in mediating triple-negative breast cancer cell death via PPAR-α signaling
Kwong, S. C., Jamil, A. H. A., Rhodes, A., Taib, N. A. M., & Chung, I. (2019) · Journal of Lipid Research · doi:10.1194/jlr.m092379 · Cited by 54
A Genetically Encoded Metabolite Sensor for Malonyl-CoA
Ellis, J. M., & Wolfgang, M. J. (2012) · Chemistry & Biology · doi:10.1016/j.chembiol.2012.08.018 · Cited by 55
MicroRNA in Metabolic Re-Programming and Their Role in Tumorigenesis
Tomasetti, M., Amati, M., Santarelli, L., & Neužil, J. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050754 · Cited by 57
Activation of a Novel Calcineurin-mediated Insulin-like Growth Factor-1 Receptor Pathway, Altered Metabolism, and Tumor Cell Invasion in Cells Subjected to Mitochondrial Respiratory Stress
Guha, M., Srinivasan, S., Biswas, G., & Avadhani, N. G. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m611693200 · Cited by 54
PIK3CA mutant tumors depend on oxoglutarate dehydrogenase
Ilić, N., Birsoy, K., Aguirre, A. J., Kory, N., Pacold, M. E., Singh, S., Moody, S. E., DeAngelo, J. D., Spardy, N. A., Freinkman, E., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1617922114 · Cited by 55
MUC1 oncoprotein promotes autophagy in a survival response to glucose deprivation
Kufe (2009) · International Journal of Oncology · doi:10.3892/ijo_00000300 · Cited by 54
Immune-mediated anti-tumor effects of metformin; targeting metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin
Bahrambeigi, S., & Shafiei‐Irannejad, V. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.113787 · Cited by 51
Targeting Cell Metabolism as Cancer Therapy
Ngoi, N. Y. L., Eu, J. Q., Hirpara, J. L., Wang, L., Lim, J. S. J., Lee, S. C., Lim, Y., Pervaiz, S., Goh, B. C., & Wong, A. L. A. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7947 · Cited by 52
PI3K-AKT Pathway Modulation by Thymoquinone Limits Tumor Growth and Glycolytic Metabolism in Colorectal Cancer
Karim, S., Burzangi, A. S., Ahmad, A., Siddiqui, N. A., Ibrahim, I. M., Sharma, P., Abualsunun, W. A., & Gabr, G. A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23042305 · Cited by 51
Determination of the protein expression profiles of breast cancer cell lines by quantitative proteomics using iTRAQ labelling and tandem mass spectrometry
Calderón-González, K. G., Rustarazo, M. L. V., Labra‐Barrios, M. L., Bazán-Méndez, C. I., Tavera-Tapia, A., Herrera-Aguirre, M. E., del Pino, M. M. S., Gallegos-Pérez, J. L., González‐Márquez, H., Hernández-Hernández, J. M., et al. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2015.04.018 · Cited by 50
High Levels of ROS Impair Lysosomal Acidity and Autophagy Flux in Glucose-Deprived Fibroblasts by Activating ATM and Erk Pathways
Song, S. B., & Hwang, E. S. (2020) · Biomolecules · doi:10.3390/biom10050761 · Cited by 47
Autophagy as a mechanism for anti-angiogenic therapy resistance
Chandra, A., Rick, J. W., Yagnik, G., & Aghi, M. K. (2019) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2019.08.031 · Cited by 54
Mitoplasticity: Adaptation Biology of the Mitochondrion to the Cellular Redox State in Physiology and Carcinogenesis
José, C., Melser, S., Bénard, G., & Rossignol, R. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2011.4357 · Cited by 51
Targeting Glucose Metabolism
Madhok, B., Yeluri, S., Perry, S., Hughes, T. A., & Jayne, D. G. (2010) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e3181e84dec · Cited by 46
Metabolic reprogramming by tobacco-specific nitrosamines (TSNAs) in cancer
Sarlak, S., Lalou, C., Amoêdo, N. D., & Rossignol, R. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.09.001 · Cited by 50
Simultaneously targeting SOAT1 and CPT1A ameliorates hepatocellular carcinoma by disrupting lipid homeostasis
Ren, M., Xu, H., Xia, H., Tang, Q., & Bi, F. (2021) · Cell Death Discovery · doi:10.1038/s41420-021-00504-1 · Cited by 45
Disrupting the CH1 Domain Structure in the Acetyltransferases CBP and p300 Results in Lean Mice with Increased Metabolic Control
Bedford, D. C., Kasper, L. H., Wang, R., Chang, Y., Green, D. R., & Brindle, P. K. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.06.010 · Cited by 43
T cell receptor-mediated activation is a potent inducer of macroautophagy in human CD8(+)CD28(+) T cells but not in CD8(+)CD28(-) T cells
Arnold, C. R., Pritz, T., Brunner, S., Knabb, C., Salvenmoser, W., Holzwarth, B., Thedieck, K., & Grubeck-Loebenstein, B. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.01.018 · Cited by 42
Regulation of PI3K signaling in cancer metabolism and PI3K-targeting therapy
Han, B., Lin, X., & Hu, H. (2024) · Translational Breast Cancer Research · doi:10.21037/tbcr-24-29 · Cited by 44
Prediction of EGFR and KRAS mutation in non-small cell lung cancer using quantitative 18F FDG-PET/CT metrics
Minamimoto, R., Jamali, M., Gevaert, O., Echegaray, S., Khuong, A., Hoang, C. D., Shrager, J. B., Plevritis, S. K., Rubin, D. L., Leung, A. N. C., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.17782 · Cited by 43
A Comprehensive Biological and Synthetic Perspective on 2-Deoxy- d -Glucose (2-DG), A Sweet Molecule with Therapeutic and Diagnostic Potentials
Wijayasinghe, Y. S., Bhansali, M. P., Borkar, M. R., Chaturbhuj, G. U., Muntean, B. S., Viola, R. E., & Bhansali, P. R. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c01737 · Cited by 41
Glucose metabolism and angiogenesis in granulosa cell tumors of the ovary: Activation of Akt, expression of M2PK, TKTL1 and VEGF
Schmidt, M., Kämmerer, U., Segerer, S. E., Cramer, A., Kohrenhagen, N., Dietl, J., & Voelker, H.-U. (2008) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2008.02.009 · Cited by 42
Apoptosis in Carcinogenesis and Chemotherapy
Chen, G. G., & Lai, P. B. S. (2009) · Springer eBooks · doi:10.1007/978-1-4020-9597-9 · Cited by 49
The Intratumoral Heterogeneity of Cancer Metabolism
Nabi, K., & Le, A. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-77736-8_10 · Cited by 42
T cell metabolism and the immune response
Verbist, K., Wang, R., & Green, D. R. (2012) · Seminars in Immunology · doi:10.1016/j.smim.2012.12.006 · Cited by 41
Systems biology of the metabolic network regulated by the Akt pathway
Mosca, E., Barcella, M., Alfieri, R. R., Bevilacqua, A., Canti, G. L., & Milanesi, L. (2011) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.08.004 · Cited by 40
The Role of Glucose Metabolism and Glucose-Associated Signalling in Cancer
Wittig, R., & Coy, J. F. (2007) · Perspectives in Medicinal Chemistry · doi:10.1177/1177391x0700100006 · Cited by 58
Effects of topoisomerase inhibitors that induce DNA damage response on glucose metabolism and PI3K/Akt/mTOR signaling in multiple myeloma cells.
(2015) · Europe PMC (PubMed Central) · Cited by 39
Context-dependent responses of Drosophila intestinal stem cells to intracellular reactive oxygen species
Chen, F., Su, R., Ni, S., Liu, Y., Huang, J., Li, G., Wang, Q., Zhang, X., & Yang, Y. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101835 · Cited by 38
AMP kinase signaling determines whether c-Jun N-terminal kinase promotes survival or apoptosis during glucose deprivation
Yun, H., Kim, H.-S., Lee, S., Kang, I., Kim, S. S., Choe, W., & Ha, J. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn259 · Cited by 39
From Genotype to Functional Phenotype: Unraveling the Metabolomic Features of Colorectal Cancer
Bathe, O. F., & Farshidfar, F. (2014) · Genes · doi:10.3390/genes5030536 · Cited by 39
Upregulation of glucose metabolism by NF-κB2/p52 mediates enzalutamide resistance in castration-resistant prostate cancer cells
Cui, Y., Nadiminty, N., Liu, C., Lou, W., Schwartz, C. T., & Gao, A. C. (2014) · Endocrine Related Cancer · doi:10.1530/erc-14-0107 · Cited by 38
Managing lipid metabolism in proliferating cells: New perspective for metformin usage in cancer therapy
Lettieri‐Barbato, D., Vegliante, R., Desideri, E., & Ciriolo, M. R. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2014.02.003 · Cited by 39
Concerted metabolic shift in early forebrain alters the CSF proteome and depends on cMYC downregulation for mitochondrial maturation
Fame, R. M., Shannon, M. L., Chau, K. F., Head, J. P., & Lehtinen, M. K. (2019) · Development · doi:10.1242/dev.182857 · Cited by 38
Tumour friend or foe
Svensson, R. U., & Shaw, R. J. (2012) · Nature · doi:10.1038/485590a · Cited by 39
Targeting metabolic reprogramming in hepatocellular carcinoma to overcome therapeutic resistance: A comprehensive review
Wang, Q., Liu, J., Chen, Z., Zheng, J., Wang, Y., & Dong, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116021 · Cited by 44
S6K1 determines the metabolic requirements for BCR-ABL survival
Barger, J. F., Gallo, C. A., Tandon, P., Liu, H., Sullivan, A. P., Grimes, H. L., & Plas, D. R. (2012) · Oncogene · doi:10.1038/onc.2012.70 · Cited by 38
AMPK in Lymphocyte Metabolism and Function
Andris, F., & Léo, O. (2014) · International Reviews of Immunology · doi:10.3109/08830185.2014.969422 · Cited by 38

Authors: Buzzai, M., Bauer, D. E., Jones, R. G., DeBerardinis, R. J., Hatzivassiliou, G., Elstrom, R. L., & Thompson, C. B.
Affiliations: Abramson Cancer Center (US)
Children's Hospital of Philadelphia (US)
Corresponding author: Thompson, Craig B
ORCID: Bauer, Daniel E
Jones, Russell G
DeBerardinis, Ralph J
Hatzivassiliou, Georgia
Thompson, Craig B
Venue: Oncogene
Publisher: Springer Science and Business Media LLC
Published: 2005-04-04
Volume: 24
Issue: 26
Pages: 4165-4173
ISSN: 0950-9232 (ISSN-L)
1476-5594
DOI: 10.1038/sj.onc.1208622
OpenAlex: W1964353872
Cited by: 357
References: 29
Citations by year: 2025: 8 · 2024: 6 · 2023: 11 · 2022: 11 · 2021: 13 · 2020: 14 · 2019: 27 · 2018: 16 · 2017: 17 · 2016: 19 · 2015: 15 · 2014: 35 · 2013: 23 · 2012: 34
FWCI: 5.90
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Oncogene (publishedVersion)
PubMed (publishedVersion)
Funders: Damon Runyon Cancer Research Foundation
University of Pennsylvania
National Institutes of Health
National Institute of General Medical Sciences (5T32-GM008638-08, T32GM008638)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
Keywords: Akt, glucose deprivation, fatty acid beta-oxidation, AMPK, AICAR, glioblastoma, rapamycin, cap-dependent translation, bezafibrate, methyl pyruvate, cancer metabolism, energy sensing, cell survival
MeSH terms: Aminoimidazole Carboxamide, Cell Survival, Fatty Acids, Glioma, Glucose, Humans, Hypoglycemic Agents, Oxidation-Reduction, Protein-Tyrosine Kinases, Proto-Oncogene Proteins, Ribonucleotides, Tumor Cells, Cultured, Protein Serine-Threonine Kinases, Proto-Oncogene Proteins c-akt

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid β-oxidation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks